Elevated levels of protein tyrosine nitration have been found in various neurodegenerative diseases and age-related pathologies. Until recently, however, the lack of an efficient enrichment method has prevented the analysis of this important low-level protein modification. We have developed a method that specifically enriches nitrotyrosine-containing peptides so that both nitrotyrosine peptides and specific nitration sites can be unambiguously identified with LC-MS/MS. The procedure consists of the derivatization of nitrotyrosine into free sulfhydryl groups followed by high efficiency enrichment of sulfhydryl-containing peptides with thiopropyl sepharose beads. The derivatization process includes: (1) acetylation with acetic anhydride to block all primary amines, (2) reduction of nitrotyrosine to aminotyrosine, (3) derivatization of aminotyrosine with N-Succinimidyl S-Acetylthioacetate (SATA), and (4) deprotection of S-acetyl on SATA to form free sulfhydryl groups. The high specificity of this method is demonstrated by the contrasting percentage of nitrotyrosine-derivatized peptides in the identified tandem mass spectra between enriched and unenriched samples. Global analysis of unenriched in vitro nitrated human histone H1.2, bovine serum albumin (BSA), and mouse brain homogenate samples had 9%, 9%, and 5.9% of identified nitrotyrosine-containing peptides, while the enriched samples had 91% , 62%, and 35%, respectively. Duplicate LC-MS/MS analyses of the enriched mouse brain homogenate identified 150 unique nitrated peptides covering 102 proteins with an estimated 3.3% false discovery rate.
Introduction
Tyrosine nitration of proteins is generated by reactive nitrogen species either from the inflammatory cell defense mechanism or from a combination of nitric oxide synthase activity with a high rate of oxidative metabolism. [1] [2] [3] [4] [5] Increased levels of nitrotyrosine in a variety of tissues have been identified in over 80 different pathologies, 6 including various neurodegenerative diseases [6] [7] [8] [9] as well as in normal biological aging. [10] [11] [12] [13] [14] [15] Tyrosine nitration can alter protein structure and function, affect its biological half-life, inactivate enzymes and receptors that depend on tyrosine residues for their activity, and prevent phosphorylation of tyrosine residues important for signal transduction. 15, 16 In addition, recent work has shown that tyrosine nitration can have a regulatory role in redox signaling. In this regard, reversible nitration in response to redox conditions has been demonstrated in mitochondria for proteins critical for energy and antioxidant homeostasis. 17 Nitrotyrosine has been suggested and used as a biomarker fordiagnosisofoxidativestress-inducedpathologicalconditions. [18] [19] [20] Typically, identification and quantification of nitrotyrosine has involved measuring the free nitrotyrosine either in plasma or generated by protein hydrolysis applying various detection methods, for example, LC-UV, LC-MS, LC-ECD, and GC-MS. [19] [20] [21] [22] However, these methods only provide an overall level of nitration as no specific protein identification or nitration site information can be obtained.
To correlate tyrosine nitration with any biological dysfunction and elucidate the role of nitrotyrosine in the signal transduction process, knowing the precise location and extent of tyrosine nitration within a given protein is necessary. To this end, various protein separation methods coupled with mass spectrometry (MS)-based bottom-up proteomic approaches have been applied to identify nitrotyrosine proteins and locate nitration sites. 15 Generally in these studies, different protein separation methods such as 2D-gel electrophoresis, 23, 24 C4 reversed-phase LC (RPLC), 25 and in-solution isoelectrofocusing 14 coupled with SDS-PAGE were used to separate the protein mixture followed by immunostaining with an anti-nitrotyrosine antibody. The nitrotyrosine-containing bands were identified by in-gel digestion and tandem MS (i.e., MS/MS) analysis. Although peptide mass fingerprinting has been used in earlier studies, 26 MS/MS has been proven to be the detection method of choice for unambiguous identification of tyrosine nitration sites. 15 New sites of tyrosine nitration have been identified from various tissues using the methods previously mentioned; however, typically only a few nitrotyrosine proteins have been identified due to limitations that are associated with analysis sensitivity, nitrotyrosine antibody specificity, and protein separation methods. [27] [28] [29] More recently, we have applied multidimensional LC (SCX coupled with RPLC)-MS/MS to extensively characterize the mouse brain proteome, which resulted in the identification of 31 unique nitrotyrosine sites in 29 different proteins. 6 More than half of the nitrated proteins identified were involved in neurodegenerative diseases. 6 Although this approach shows advantages over previously reported gel-based methods, the detection of many lower abundant nitrotyrosine proteins remains problematic.
For proteome-wide analysis of this low-abundance protein modification, a specific enrichment approach prior to MS analysis is highly desirable. To date, no effective nitrotyrosine peptide enrichment approach has been reported. One study recently reported an enrichment strategy involving the reduction of 3-nitrotyrosine to 3-aminotyrosine, coupling to a cleavable biotin affinity tag, and capturing with a streptavidin affinity column. 30 This approach was sound in principle, but suffered from the limitations of nonspecific derivatization reactions to aminotyrosine in the presence of other primary amines as well as of the nonspecific binding during avidin affinity purification. Indeed, this approach has only been demonstrated for single proteins. Here, we report a novel enrichment strategy with improved derivatization specificity and high efficiency capture of nitrotyrosine peptides based upon a highly specific cysteinyl (or sulfhydryl-containing) peptide enrichment strategy previously developed in our laboratory. 31 The effectiveness of this approach coupled with MS for nitrotyrosine site identification is evaluated using standard peptides, proteins, and in vitro nitrated whole mouse brain homogenate and shown to provide a significant improvement for the characterization of the nitrotyrosine proteome.
Experimental Procedures
1. Chemicals and Materials. All chemicals, unless specified otherwise, were from Sigma-Aldrich (St. Louis, MO). N-Succinimidyl S-Acetylthioacetate (SATA), micro-BCA assay kits, and Handee Mini-Spin columns were purchased from Pierce Biotech (Rockford, IL). Thiopropyl sepharose 6B beads were obtained from Amersham Biosciences (Uppsala, Sweden). RapiGest SF reagent (sodium 3-[2-methyl-2-undecyl-1,3-dioxolan-4-yl)methoxy]-1-propanesulfonate) was from Waters Corporation (Bedford, MA). Sequencing-grade modified trypsin was purchased from Promega (Madison, WI). The standard nitrated peptide was purchased from Global Peptide Services (Fort Collins, CO) with 24 u modification on the N-terminus. The characterization of this peptide is in Supporting Information.
In Vitro Nitration of Model Proteins and Mouse Brain
Tissue Homogenate. To nitrate model proteins, human histone 1.2 and bovine serum albumin (BSA), 1 mg (1 mg/mL) of protein in 50 mM PBS (pH 7.4) or NH 4HCO3 (pH 7.8) was treated with 1 mM peroxynitrite (Calbiochem, San Diego, CA) by bolus addition. 32 After quick vortexing, the sample was incubated for 10 min on ice and then snap-frozen in liquid N2 until further use.
A C57BL/6J inbred strain male mouse (Jackson Laboratory, Bar Harbor, ME) was sacrificed following deep anesthesia with isoflurane at 9 weeks of age. The whole brain was dissected and then snap-frozen in liquid N 2. To prepare mouse brain homogenate, 50 mM NH4HCO3 (pH 7.8) containing 0.5% RapiGest was added to the brain tissue. Tissue homogenization was performed with a pestle type mini-homogenizer (SigmaAldrich, St. Louis, MO) three times with 0.5 min duration each time. The sample was kept on ice during the intermittent periods. The resultant homogenates (5 mg/mL, ∼10 mg of total proteins) were treated with 2 mM peroxynitrite by bolus addition. After quick vortexing, the sample was incubated for 10 min on ice and then snap-frozen in liquid N2 before further processing.
3. Protein Digestion for in Vitro Nitrated Protein Samples. RapiGest was added to the in vitro nitrated standard proteins for a final concentration of 0.5%. Proteins were denatured by boiling the samples for 5 min and chilled on ice. Disulfide bonds in protein were reduced by 5 mM dithiothreitol (DTT) with 1 h incubation at 37°C, amd the sulfhydryl groups were alkylated with 20 mM iodoacetamide at room temperature for 1 h in the dark. Samples were then diluted 5-fold with 50 mM NH 4HCO3 (pH 7.8) to reduce the RapiGest concentration to below 0.1% prior to the addition of sequencing-grade modified trypsin at a ratio of 1:50 (w/w, enzyme/protein). Samples were digested at 37°C for 3 h with gentle shaking. The RapiGest was decomposed by acidifying the sample with 500 mM HCl at 1/10 volume and incubated for 45 min at 37°C before centrifuging at 16 000g for 10 min to remove the decomposed RapiGest. The cleaned sample was lyophilized in a Speed-Vac (Thermo Savant, Milford, MA).
In vitro nitrated mouse brain homogenate was processed as follows. The protein mixture was denatured with 6 M Guanidine-HCl, and disulfide bonds were reduced with 5 mM tributyl phosphine (TBP) at 45°C for 1 h followed by addition of 15 mM iodoacetamide. After alkylation of the cysteines, the mixture was diluted 6-fold with 50 mM NH4HCO3 (pH 7.8).
Trypsin was added at a ratio of 1:50 (enzyme/protein), and the proteins were digested at 37°C overnight. The final digestion mixture was acidified to remove RapiGest prior to C18 SPE cleanup.
Acetylation of Primary Amines.
The dried tryptic peptides were redissolved in 50 mM NaHCO3 solution (4 mg/mL), and the pH was adjusted to 8.5. Acetic anhydride (totally 200-fold molar excess) in 50 µL of acetonitrile was added to the peptides in three times. The molar excess was calculated with respect to estimated molar quantity of primary amines in peptides, assuming that average MW of each peptide is 1500 and there are one N-termini and 2 lysines in each peptide. Before each addition of acetic anhydride, the pH was readjusted to above 7 with NH4OH. After the final addition, the sample was incubated at 30°C for 1 h. 33 To reverse the possible O- acetylations, hydroxylamine was added at a final concentration of 20 mM and incubated for 20 min. 33 The final reaction mixture was diluted with water to reduce the acetonitrile content to below 5% followed by C18 SPE clean up. The eluted peptides from the SPE column were dried in a Speed-Vac. 5. Reduction of Nitrotyrosine to Aminotyrosine. The acetylated peptide samples were redissolved in 50 mM sodium phosphate buffer (4 mg/mL), and the pH was adjusted to 8. Concentrated Na 2S2O4 solution was added (50-fold molar excess to the expected molar amount of nitrated tyrosines in the sample, assuming that tyrosine natural occurrence in proteins is 3.25% (http://prowl.rockefeller.edu/ aainfo/struct.htm) and 50% of all tyrosines could be nitrated) to reduce the 3-nitrotyrosine to 3-aminotyrosine. 34 The mixture was incubated at room temperature for 20 min followed by C18 SPE cleanup to remove the excess reducing agent. The eluted peptides from the SPE column were dried in a Speed-Vac.
6. S-Acetylthioacetylation of Aminotyrosine and Deprotection of S-Acetyl Group. The above dried peptide residue was redissolved in 100 mM sodium acetate solution (4 mg/ mL), and the pH was adjusted to 5. Then SATA/acetonitrile solution was added at a 50-fold molar excess to the expected amount of aminotyrosines, and the mixture was incubated at 37°C overnight. The reaction mixture was further deprotected with 0.5 M NH 2OH to expose the free sulfhydryls for the following enrichment step. The final mixture was cleaned up by C18 SPE column to remove salt and excess reagents. To minimize the oxidation of sulfhydryl groups during the cleanup process, the C18 SPE eluting solution (80/20/0.1%, CH3CN/H2O/ TFA) contained 2 mM EDTA. 35 7. Enrichment of Sulfhydryl-Derivatized Peptides. The peptides derived from the reduced 3-nitrotyrosine were isolated by a recently reported solid-phase cysteinyl (or sulfhydrylcontaining) peptide enrichment approach. 31 Briefly, the peptide residue was redissolved in 100 µL of coupling buffer that consisted of 50 mM Tris-HCl, 1 mM EDTA, pH 7.5, then transferred to a Handee Mini-Spin column that contained ∼100 µL of pre-washed thiopropyl sepharose 6B resin. The sulfhydrylderivatized peptides were captured by the sepharose beads during 1 h incubation at room temperature with gentle shaking. The unbound portion of the peptide sample was removed from the resin by stringent washing; first with the coupling buffer, followed by 2 M NaCl, then 80% acetonitrile/0.1% TFA solution and again with the coupling buffer. The captured sulfhydryl peptides were released by incubating the resin with 100 µL of 20 mM freshly prepared DTT solution at room temperature for 30 min. The released peptides were further alkylated with 40 mM iodoacetamide for 1 h at room temperature in the dark. The alkylated peptide samples were then desalted using C 18 SPE columns. After concentrating the eluting fraction to a small volume, peptides were subjected to capillary LC-MS/MS analysis.
Capillary LC-MS/MS Analysis.
The enriched peptides containing derivatized 3-nitrotyrosine were analyzed with automated capillary HPLC systems 36 coupled online with an LTQ ion trap mass spectrometer (ThermoElectron, San Jose, CA) by using an electrospray ionization interface. The reversedphase capillary columns were prepared by slurry packing 3-µm Jupiter C18 particles (Phenomenex, Torrence, CA) into either a 150 µm i.d. × 65 cm or 50 µm i.d. × 65 cm fused silica capillary (Polymicro Technologies, Phoenix, AZ). The mobile phase solvents consisted of (A) 0.2% acetic acid and 0.05% TFA in water and (B) 0.1% TFA in 90% acetonitrile. An exponential gradient was used for the separation, which started with 100% A and gradually increased to 60% B over 100 min. The instrument was operated in data-dependent mode with an m/z range of 400-2000. The 10 most abundant ions from each MS scan were selected for further MS/MS analysis by using a normalized collision energy of 35%. Dynamic exclusion of 60 s was applied to avoid repeated analyses of the same abundant precursor ion.
9. Data Analysis. Sequest (ThermoElectron) was used for peptide identification by searching LC-MS/MS data against specific fasta files (BSA fasta file for in vitro nitrated BSA sample, and a custom-made human histone database of all family members of human histones for in vitro nitrated human histone H1.2 sample) or the mouse International Protein Index (IPI) database (Version 3.09) for the mouse brain homogenate. A parameter which incorporates the following modifications was used in the Sequest search for enriched peptides: static mass modification for cysteinyl residues (carbamidomethylation with iodoacetamide, 57.02 u), static modification for N-terminal amine (acetylation, 42.01 u), dynamic modification for methionine (oxidation, 16.00 u), dynamic modification for lysine (acetylation, 42.01 u), and dynamic modification for tyrosine (corresponding to the final modification as illustrated in the enrichment scheme, 146.01 u). For comparison purposes, tryptic peptides obtained from in vitro nitrated mouse brain homogenate were submitted for global proteomic analysis prior to enrichment. The parameter used for unenriched peptides was as follows: dynamic mass modification for cysteinyl residues (carbamidomethylation with iodoacetamide, 57.02 u), dynamic modification for methionine (oxidation, 16.00 u), and dynamic modification for tyrosine (nitration, 44.99 u). The following criteria used to filter raw Sequest results were established by applying a probability-based evaluation using sequence-reversed database searching as previously described to provide >95% overall confidence level for the entire set of different peptide identifications (<5% false-positive rate), 37 and further confirmed in the mouse brain proteome analysis. 38 (1) Xcorr g1.6 for charge state +1 fully tryptic peptides; (2) Xcorr g2.4 for charge state +2 fully tryptic peptides and Xcorr g4.3 for +2 partially tryptic peptides; and (3) Xcorr g3.2 for charge state +3 fully tryptic peptides and Xcorr g4.7 for +3 partially tryptic peptides. The delta correlation value (∆Cn) g 0.1 was used in all cases. Additionally, each data set was searched against the reversed mouse IPI database to estimate the False Discovery Rate of the results.
Results and Discussion
Our enrichment strategy (Scheme 1) involves specific derivatization of 3-nitrotyrosine to form free sulfhydryl functional groups, taking advantage of the highly efficient sulfhydrylcontaining peptide enrichment method developed in our research group. 31 The derivatization scheme starts with blocking N-terminal R-amine and lysine -amine in peptides, followed by reducing the nitrotyrosine to aminotyrosine by dithionite. The resulting aminotyrosine is then reacted with SATA, an N-hydroxysuccinimide (NHS) ester used for introducing protected sulfhydryl groups into proteins, peptides, and other molecules. 39 As the only available primary amine, the tyrosyl amine reacts with NHS ester to form a stable, covalent amide bond by nucleophilic attack. The free sulfhydryls are formed following the hydroxylamine-mediated deprotection step and can be effectively captured with thiopropyl sepharose beads in the subsequent peptide enrichment step. Captured peptides are eluted by cleaving the new disulfide bond on the resin with a high concentration of DTT. 31 To avoid the competition of native cysteines with the derivatized sulfhydryl groups from 3-nitrotyrosine, samples are reduced and alkylated before a Symbols are the same as in the legend of Table 2 .
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Zhang et al. digestion, which makes the newly generated sulfhydryl group on the tyrosine the only one available in the enrichment step. Primary amines, that is, N-terminal R-and lysine -amines, have pKa values of ∼8 and ∼9.5, respectively. On the other hand, the pKa of the -NH2 in aminotyrosine is ∼5. In a previous report, it was suggested that amine derivatization reaction can be directed specifically at aminotyrosine if pH was 5. 30 To examine the relative reactivities of native peptide amines and aminotyrosines, a standard peptide containing lysine and aminotyrosine was used to react with SATA at pH 5. It was found that both of the amines on lysine and aminotyrosine can be reactive, as shown in Figure 1 of the product ion spectrum from the same [M + 2H] 2+ ions of the two different SATA modification products, in which specific ions (expected b4-b8 and y8-y12 ions) corresponding to SATA modification either on lysine or on aminotyrosine were identified. Primary amines susceptible to SATA reaction at pH 5 were further confirmed by reaction of SATA with other primary aminecontaining peptides as well as a tryptic peptide mixture from BSA protein (Table 1) . These results clearly show that R-and -primary amines are highly reactive with SATA, forming partially or fully SATA-acetylated products. At pH 5 a total of 45% of lysine-containing peptides reacted with SATA. Therefore, these results demonstrate that the specificity required for enrichment of nitrotyrosine is not provided by direct labeling of aminotyrosine with SATA in the presence of R-and -amino Tables 2 and 3. groups, thus, validating our strategy (Scheme 1) to block all the R-and -amines in peptides before reduction of nitrotyrosine to aminotyrosine, making aminotyrosine the only reactive amine to SATA. The primary amine blocking strategy was initially tested with a standard peptide containing nitrotyrosine. This model peptide represents a portion of the sequence of calmodulin, which contains Y 99 , a nitration-sensitive site. 40 After acetylation with acetic anhydride to block the amino group on lysine, reduction of nitrotyrosine to aminotyrosine, derivatization of the aminotyrosine with SATA, deprotection to expose the free sulfhydryl group, and alkylation of the new sulfhydryl with iodoacetamide, the final peptide was confirmed unambiguously by its product ion spectrum (Figure 2 ). An important feature about the final product is that the derivatized nitrotyrosine group is relatively stable under the CID conditions used in the LC-MS/ MS experiment, aiding peptide identification. As shown, almost complete series of abundant b-and y-ions carrying the modification site are observed with no obvious evidence of labile cleavage products from the modification site. Similar results have also been observed in peptides when aminotyrosine and primary amines were all acetylated with N-hydroxysuccinimide acetate, 41 in which it was reported that acetylation of aminotyrosine can enhance peptide backbone cleavage under CID conditions using ion-trap mass spectrometers. We further estimated the efficiency of each reaction step by plotting the selected ion chromatograms for the expected products and underivatized starting materials, taking into account all the charged ions for each species and comparing the peak areas. After optimization of the reaction conditions, we were able to achieve more than 90% efficiency for each reaction step. The efficiency of each chemical reaction is labeled in Scheme 1. The selected ion chromatograms for the SATA acetylation of aminotyrosine step are shown in Figure 3 .
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We next applied this strategy to the enrichment of nitrotyrosine peptides derived from in vitro nitrated proteins. We first tested this approach with in vitro nitrated human histone H1.2 which contains only a single tyrosine residue. In addition, the lysine content in histone H1.2 is about 28%, which poses a challenging test for this enrichment method, especially with respect to the first acetylation step for blocking primary amines. Therefore, 200 µg of nitrated histone H1.2 was subjected to the reaction steps in Scheme 1. A single LC-MS/MS analysis provided a total of 59 identified spectra with 54 (91%) corresponding to peptides containing nitrotyrosine; in comparison, the analysis for the unenriched sample had only 9% of the identified spectra contained nitrotyrosine. The 5 non-nitrated peptides are from histone H1.2 and other histone-associated proteins. The 14 different nitrotyrosine peptides are shown in Table 2 ; most of the multiple nitrotyrosine peptides were the result of different tryptic cleavage sites. In addition to the one nitration site identified from histone H1.2, three additional nitrated peptides are identified from histone H1.1 and H1.5 which are possible sample impurities. A representative product ion spectrum is shown in Figure 4 for a relatively long 25 residue peptide containing multiple modifications, but the product ion spectrum quality is high enough for unambiguous identification of the tyrosine modification site along with the entire peptide sequence. Of note is the high efficiency of primary amine acetylation in which all of the N-termini and the majority of the lysines were acetylated.
To further test the method for enrichment of peptides from proteins with multiple nitrated tyrosine sites, BSA was chosen since this nitration-sensitive protein contains 21 tyrosine sites that can potentially be nitrated in vitro. We therefore applied this enrichment strategy to peptides from 200 µg of nitrated BSA. Sixty-five spectra were identified within one LC-MS/MS analysis, 40 (62%) of which contained derivatized nitrotyrosine peptides (compared to only 9% of identified spectra containing nitrotyrosine for the unenriched sample Finally, we extended our enrichment approach to more complex samples to identify possible nitrated peptides/ proteins from in vitro nitrated mouse brain tissue homogenate, using 3.1 mg of digested peptides for the enrichment experiment. The final enriched peptides were subjected to duplicate LC-(LTQ)MS/MS analyses. A total of 150 different nitrotyrosine peptides are confidently identified from this sample, corresponding to 102 unique proteins ( Table 4 ). The false discovery rate is estimated to be 3.3% based upon a reverse database search. Many of the identified nitrotyrosine containing proteins have been previously reported as endogenously nitrated. For example, low levels of nitrated 78 kDa glucose-regulated protein precursor, aspartate aminotransferase, and creatine kinase were found in our previously endogenous nitration study of mouse brain, 6 while acetyl-CoA acetyl transferase, ATP synthase, electron-transfer flavoprotein alpha-subunit, and malate dehydrogenase were found endogenously nitrated in muscle. 23 Approximately 35% of the identified spectra (422 different peptides) contain derivatized nitrotyrosine. A majority (>60%) of the identified non-nitrated peptides are from different proteins and were carried along during the enrichment process (listed as Supporting Information). In the global analysis of the tryptic peptides without enrichment, only about 5.9% identified peptides contain nitrotyrosine (156 of the 2618 different peptides identified from duplicate analyses contain nitrotyrosine). The total number of peptide identifications from the enriched samples has been largely limited by the LC-MS/MS platform sensitivity due to the small quantity of the enriched sample obtained from this experiment, while the global analysis is not limited by the sample quantity. Following further optimization of enrichment recovery and the use of a higher sensitivity LC-MS/MS platform, we anticipate the enrichment strategy should allow more low-abundance nitrotyrosine peptides to be identified. Also notable is that only 17.6% of identified tyrosine-containing peptides from global analysis were observed to be nitrated in vitro, which is consistent with in vitro nitration of BSA both in this work and by others. 26, 41 This observation also agrees with a previous report that suggested that in vitro tyrosine nitration was localized frequently on the protein surface and also depended on neighboring amino acids. 26, 32 Therefore, the nitrated peptides and proteins identified in the in vitro nitrated brain (listed in Table  4 ) provide evidence as to which proteins and tyrosine sites are more sensitive to oxidation.
Conclusion and Perspective
A new nitrotyrosine enrichment strategy has been developed by prior blocking of all primary amines, the derivatization of nitrotyrosine to form free sulfhydryls, and solid-phase high efficiency capture/release of derived sulfhydryl-containing peptides. The efficiency of this approach was demonstrated with standard peptides containing nitrotyrosine, in vitro nitrated model proteins histone H1.2 and BSA, and in vitro nitrated mouse brain tissue homogenate. To our knowledge, this method represents the first demonstration of nitrotyrosine peptide enrichment and identification from a complex global proteome sample.
Furthermore, this enrichment scheme can also be easily coupled with stable isotope labeling techniques such as 18 Olabeling for quantitative tyrosine nitration analysis among different biological conditions. 44, 45 One limitation of this approach is the involvement of multiple steps of derivatization and SPE cleanup steps at the peptide level, which can lead to significant sample loss. We did not apply this derivatization strategy at the protein level since some nitration sites might not be easily accessible under the less-than-optimal denaturing conditions that were used in our chemical derivatization steps. However, working at the protein level may provide better sample recovery by potentially separating unwanted salts/excessive reagents from proteins based on size through the use of various membrane-based molecular weight cutoff filters, which warrants further investigation. On the basis of the initial limited number of identifications from the in vitro nitrated brain sample, we anticipate that there are still challenges for endogeneous nitrotyrosine profiling in tissue samples from various pathological conditions. Following further optimization or coupling with other immunoaffinity approaches and with the use of high sensitivity LC-MS/MS platform, the effectiveness of this approach may be fully illustrated for the analysis of an endogenous nitrotyrosine proteome sample.
Abbreviations: LC, liquid chromatography; HPLC, highperformance liquid chromatography; RPLC, reversed-phase liquid chromatography; UV, ultraviolet; MS, mass spectrometry; ECD, electrochemical detection; GC, gas chromatography; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; SCX, strong cation exchange; CID, collision-induced dissociation; SPE, solid phase extraction; EDTA, ethylenediaminetetraacetic acid; PBS, phosphate-buffered saline.
